Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726733 | PMC |
| http://dx.doi.org/10.1177/1535759720948437 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Editorial: The magic bullet evolution in tumor therapy: novel drug conjugates for targeted delivery.
Front Pharmacol
December 2024
Faculty of Chemistry, Bielefeld University, Bielefeld, Germany.
Commentary: "In Search of a Magic Bullet for CS-AKI Prevention and Treatment".
J Thorac Cardiovasc Surg
December 2024
Department of Surgery, University of Massachusetts Medical School-Baystate, Springfield, MA.
The Iatrogenic Consequences of Medicalising Grief: Resetting the Research Agenda.
Sociol Health Illn
November 2024
University of Massachusetts, Counseling and Psychology, BEAHR Lab, Boston, Massachusetts, USA.
When the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) was published in 2013, there was a firestorm of controversy about the elimination of the bereavement exclusion. Proponents of this change and of the proposed "complicated grief" designation believed that this change would help clinicians recognise major depression in the context of recent bereavement. Other researchers and clinicians have raised concerns about medicalising grief.
View Article and Find Full Text PDFUses of Molecular Docking Simulations in Elucidating Synergistic, Additive, and/or Multi-Target (SAM) Effects of Herbal Medicines.
Molecules
November 2024
Department of Chemical and Environmental Engineering, Faculty of Engineering, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
The philosophy of herbal medicines is that they contain multiple active components that target many aspects of a given disease. This is in line with the recent multiple-target strategy adopted due to shortcomings with the previous "magic bullet", single-target strategy. The complexity of biological systems means it is often difficult to elucidate the mechanisms of synergistic, additive, and/or multi-target (SAM) effects.
View Article and Find Full Text PDFAntibody-drug conjugates: prospects for the next generation.
Drug Discov Today
December 2024
Institut des Sciences Pharmaceutiques et Biologiques (ISPB), Faculté de Pharmacie, Université Claude Bernard Lyon 1, Univ Lyon, 69373 Lyon, France; Small Molecules for Biological Targets Team, Centre de recherche en cancérologie de Lyon, Centre Léon Bérard, CNRS 5286, INSERM 1052, Université Claude Bernard Lyon 1, Univ Lyon, 69373 Lyon, France. Electronic address:
The concept of a 'magic bullet' was first introduced by Paul Ehrlich in the early 1900s, he foresaw the advent of targeted therapies and the specific killing of harmful cells and/or microorganisms. However, these therapies were only used in the clinic after the second half of the 20th century with the development of specific monoclonal antibodies. To date, 13 antibody-drug conjugates (ADCs) are commercially available.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!